Geisinger Health System’s Neuroscience Institute is using the latest optical molecular imaging technology from Carestream Molecular Imaging as part of its cutting-edge research of brain cancer treatment.

Geisinger Health System’s Neuroscience Institute is using the latest optical molecular imaging technology from Carestream Molecular Imaging as part of its cutting-edge research of brain cancer treatment. The objective of this research is to make surgery for brain tumors and inflammatory lesions simpler and more precise by using fluorescent nanospheres to more easily visualize tumors and lesions during treatment procedures.

Geisinger’s neuroscience lab chose the company’s KODAK In-Vivo Multispectral Imaging System FX to assess which nanoparticles would be most efficacious for image-guided brain surgery in patients in the near future.

Dr. Toms said, These techniques are designed to make needle placement for biopsies more precise and improve the completeness of tumor resection.  Ultimately this technology should decrease complications and improve survival for a variety of tumors

The KODAK In-Vivo Multispectral Imaging System FX is designed to precisely locate and monitor changes in molecular activity of specific cells or organs, such as the brain—long morphological changes can be detected—expediting the development of effective therapeutics for disease treatment.